36 results
424B5
SLNO
Soleno Therapeutics Inc
29 Sep 23
Prospectus supplement for primary offering
4:51pm
pricing limitations may hinder our ability to recoup our investment in one or more product candidates, even if our product candidates obtain regulatory
424B5
SLNO
Soleno Therapeutics Inc
27 Sep 23
Prospectus supplement for primary offering
5:26pm
. Adverse pricing limitations may hinder our ability to recoup our investment in one or more product candidates, even if our product candidates obtain
424B5
SLNO
Soleno Therapeutics Inc
30 Mar 22
Prospectus supplement for primary offering
5:21pm
to recoup our investment in one or more planned products, even if our planned products obtain regulatory approval.
Our ability to commercialize our
424B5
u5jdbfvygt pnr37r
28 Mar 22
Prospectus supplement for primary offering
4:53pm
424B5
8vay t59prnn7p
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
0duws lbtk2tk
23 Jun 20
Prospectus supplement for primary offering
4:06pm
424B5
o2j9g8ydrd ecq
25 Oct 19
Prospectus supplement for primary offering
12:00am
424B5
izivuwa4w t0kr
22 Oct 19
Prospectus supplement for primary offering
4:24pm
424B3
ars7 n8qq1n3fb4xm6
12 Apr 19
Prospectus supplement
4:41pm